State of the Science
Discovering new treatments for LAM requires a multidisciplinary
approach, bringing together laboratory and clinical researchers from
diverse areas of expertise--for example, those interested in cell
signaling, estrogen biology, pulmonary pathophysiology, vascular
biology, and cancer, among other disciplines. It is an approach that
is in line with the multidisciplinary perspective outlined by the
U.S. National Institutes of Health (NIH) Roadmap for Medical Research,
and is as a guiding principal for research funding and support.
To foster interdisciplinary collaboration to find a LAM treatment or
cure, the LTA actively recruits the best and the brightest researchers
in the world to work on LAM, sponsors seminars
focused on finding an effective LAM treatment or cure, and convenes
regular high-powered brainstorming and problem-solving meetings and
summits for the scientific, medical, and even patient
communities.
Moreover, LTA matches the highest-priority research projects with the
researchers, labs and institutions best equipped to execute them. We
recruit scientists, facilitate research collaborations and accept and
review research proposals on a rolling basis. We
facilitate the highest quality and highest impact LAM research by
funding scientific awards, supporting increased dialogue and
collaboration among LAM researchers and leaders in relevant fields
across disciplines and institutions.
Sponsoring, recruiting, convening and promoting LAM research, we bring
together the best and the brightest minds from diverse areas of
expertise to focus on finding a treatment for LAM in the fastest time
possible. We aggressively fund high-impact collaborative research
initiatives, such as:
-
Over 85 ad hoc or "as needed" meetings each year;
-
Monthly seminars at Harvard Medical School accessible
to researchers and clinicians globally;
-
International state-of-the-science Summits held on an
as-needed basis throughout the year;
-
Fostering and funding travel grants to over 75 researchers per year to
attend face-to-face problem solving meetings and to get the training
they need in specialized laboratories throughout the world;
-
Connecting Patients and Researchers. Clinical care that stays on the
cutting edge of research developments;
-
Facilitating Patient-Researcher contact earlier in the research
process than is traditionally the case;
-
Innovating to ensure that information that patients choose to share
about their experience of their disease accessible in appropriate ways
and used efficiently and effectively by the research and clinical
communities;
-
Supporting patient access to expert informed specialist care for
effective disease management at top-level institutions throughout the
world from pulmonology to reproductive endocrinology and
interventional radiology;
-
Eliminating Barriers. Prioritizing work to overcome key barriers to
accelerating treatment research;
-
Ensuring fast and effective tissue procurement, banking, distribution;
-
Supporting patient efforts to become tissue donors; Supporting
researcher interest in efficient access to LAM tissue;
-
Strategic focus of resources to overcome cell isolation/ cell
culturing/ cell line growth challenges and barriers to effective
disease models;
-
Working to ensure that resources spent on LAM at all stages and in all
areas of research and infrastructure development for the community are
coordinated to ensure maximum impact from any investment;
-
Fast-Tracking Core Research, such as leveraging leading-edge expertise
and cutting-edge technologies to advance LAM research in Radiographic
and other forms of Biomarker identification to enable detection of
response to therapy in advance of conventional measures, the
identification of additional genes implicated in LAM, genotyping /
expression analyses, and high-throughput combination drug screening
using libraries of already approved drugs.